G-CON Manufacturing Selected to Supply ISO 7 POD for Strike Bio

Share Article

G-CON’s autonomous POD™ provides process space for Strike Bio’s bifunctional RNA technology platform for personalized medicine

There is no other solution on the market or that can be built that allows us to have the proper environment with the ability to seamlessly scale up and expand cGMP manufacturing operations in the timeframe needed and for the cost of the POD.

Past News Releases

RSS

G-CON Manufacturing, Inc., the manufacturer of autonomous cleanroom PODs™, is pleased to announce that Strike Bio, Inc. has selected G-CON to provide an ISO 7 cleanroom POD to further advance its specific protein knockdown bifunctional short hairpin RNA (shRNA) technology. Strike’s proprietary bi-functional shRNA expression platform has been developed to target driver genes and interacting dominant pathway and co-pathway nodes to inhibit tumor growth. This technology has been shown to be effective in several cancer therapies currently in the clinical trial process.

Building on those successes, Strike Bio is purchasing an 18’W x 42’L x 11.5’H (5.49m x 12.8m x 3.51m) standard POD for further production and development of the bifunctional technology. The POD provides approximately 468 sq.ft. (43.5 sq.m.) of cleanroom space, with a 108 sq.ft. (10.0 sq.m.) area for gowning and equipment pass through. G-CON will also provide the shipping, delivery, installation, and commissioning of the POD.

“Strike Bio is a rapidly growing company with ambitious plans for expansion as we continue to advance our platform from preclinical through clinical trials. Our selection of the POD to be able to further our technology was an easy one. There is no other solution on the market or that can be built that allows us to have the proper environment with the ability to seamlessly scale up and expand cGMP manufacturing operations in the timeframe needed and for the cost of the POD,” said Dr. Donald Rao, Director of Interference Technologies.

“We are excited to provide a POD to an innovative company such as Strike,” said Maik Jornitz, President of G-Con Manufacturing, Inc. “Personalized medicine is the future and Strike’s technology is at the forefront of this movement. Given Strike’s expectation that it will scale up rather quickly, the POD was really the only solution that would work for Strike.”

The sale of this POD is the first for G-Con in the personalized medicine field, a field that is expected to grow exponentially in the coming years. In anticipation of such growth, G-Con has launched its scalable 9’W x 50’L miniPOD CT Series which includes a built in corridor system and unidirectional flow layout. Such PODs can be utilized individually or in parallel as part of a POD system.

About G-CON Manufacturing
G-CON designs and builds cleanrooms for biomanufacturing and pharmaceutical development that are comprehensive, affordable, scalable and flexible. No other product on the market or able to be built provides a better combination of such characteristics. G-CON's founders’ experience in designing, building, operating, and maintaining a variety of traditional biomanufacturing facilities and their recognition of the shortcomings of those approaches led to the creation of PODs. G-CON PODs can also be used for multiple purposes and are repurposable, instead of single purpose and fixed as are competitive offerings.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Maik Jornitz

Brittany Berryman
@G_CON_PODs
since: 12/2012
Follow >
G-CON Manufacturing

Follow us on
Visit website